QbD-PharmOptima: A New Research and Educational Generative Platform for AI-Assisted Design and Optimization of Drug Delivery Systems and Pharmaceutical Operations

Background/Objectives: The integration of artificial intelligence (AI) into pharmaceutical sciences and industry can accelerate the design and optimization of drug delivery systems and biotechnological processes and operations. Methodology: In this work, we present a novel application (a platform) developed using Google AI Studio, a web-based environment for prototyping generative AI solutions powered by highly capable models such as Gemini. The application enables rapid design of experiments (DoE), drug formulations and processes through structured prompting and automated workflows using a simple, user-friendly interface. Results: The platform could integrate formulation material attributes and critical process parameters to assist in the rational design of conventional and advanced delivery systems or any industrial process. Conclusions: This study highlights the potential of generative AI to accelerate pharmaceutical and biotechnological innovation, reduce experimental burden, and support pharmaceutical industry strategies.

Authors

Institutions

Publication Details

Journal
BioChem
Published
2026-08-18
DOI
https://doi.org/10.3390/biochem6030022
Primary Topic
Inhalation and Respiratory Drug Delivery
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

QbD-PharmOptima: A New Research and Educational Generative Platform for AI-Assisted Design and Optimization of Drug Delivery Systems and Pharmaceutical Operations

Shaimaa S. Ibrahim, Ghadir S. El-Housseiny, Rania M. Hathout
BioChem
Inhalation and Respiratory Drug Delivery
article

QbD-PharmOptima: A New Research and Educational Generative Platform for AI-Assisted Design and Optimization of Drug Delivery Systems and Pharmaceutical Operations

Shaimaa S. Ibrahim, Ghadir S. El-Housseiny, Rania M. Hathout
article en

Abstract

Background/Objectives: The integration of artificial intelligence (AI) into pharmaceutical sciences and industry can accelerate the design and optimization of drug delivery systems and biotechnological processes and operations. Methodology: In this work, we present a novel application (a platform) developed using Google AI Studio, a web-based environment for prototyping generative AI solutions powered by highly capable models such as Gemini. The application enables rapid design of experiments (DoE), drug formulations and processes through structured prompting and automated workflows using a simple, user-friendly interface. Results: The platform could integrate formulation material attributes and critical process parameters to assist in the rational design of conventional and advanced delivery systems or any industrial process. Conclusions: This study highlights the potential of generative AI to accelerate pharmaceutical and biotechnological innovation, reduce experimental burden, and support pharmaceutical industry strategies.

BioChemVol. 6(3)
Ain Shams University (EG)
Industry, innovation and infrastructure
Openalex Percentile: Top 10%
Inhalation and Respiratory Drug Delivery
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

QbD-PharmOptima: A New Research and Educational Generative Platform for AI-Assisted Design and Optimization of Drug Delivery Systems and Pharmaceutical Operations — Shaimaa S. Ibrahim, Ghadir S. El-Housseiny, et al. · BioChem (2026) | TGRS Research Map | TGRS